Literature DB >> 19504404

Faecal calprotectin and lactoferrin values during irradiation of prostate cancer correlate with chronic radiation proctitis: results of a prospective study.

Andrea Hille1, Margret Rave-Fränk, Hans Christiansen, Markus K A Herrmann, Tereza Kertesz, Robert M Hermann, Hendrik A Wolff, Markus Schirmer, Clemens F Hess, Giuliano Ramadori.   

Abstract

OBJECTIVE: Acute proctitis and chronic radiation proctitis are relevant complications of pelvic radiation. The purpose of this study was to investigate two markers of gut inflammation during and after irradiation for prostate cancer to evaluate a correlation between acute and chronic proctitis.
MATERIAL AND METHODS: Two patient groups were analysed. In group 1, stool samples from 20 patients were collected before therapy, every week during therapy, at the end of therapy, and 13 and 27 months after therapy. Group 2 comprised 47 patients who had undergone irradiation 40 months earlier. Toxicity was determined by common toxicity criteria (CTC) and the LENT soma scale. Calprotectin and lactoferrin values were determined by ELISA.
RESULTS: In group 1, acute values for both faecal markers were significantly correlated with chronic proctitis symptoms and all patients with chronic toxicity had acute proctitis symptoms with elevated faecal values. In group 2, where stool samples were solely collected 40 months after irradiation, the Pearson square test showed both a significant correlation between calprotectin and lactoferrin values and toxicity after 40 months.
CONCLUSIONS: Within a group of 19 patients followed for two years after irradiation for prostate cancer, and 47 patients tested 40 months after irradiation, increased faecal values of calprotectin and lactoferrin were significantly correlated with the occurrence of chronic proctitis. This observation should be confirmed in an expanded study.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19504404     DOI: 10.1080/00365520903039952

Source DB:  PubMed          Journal:  Scand J Gastroenterol        ISSN: 0036-5521            Impact factor:   2.423


  5 in total

Review 1.  [Radiation biology of normal tissues. Scientific progress and perspectives].

Authors:  W Dörr; C Herskind
Journal:  Strahlenther Onkol       Date:  2012-11       Impact factor: 3.621

2.  International consensus on methodological issues in standardization of fecal calprotectin measurement in inflammatory bowel diseases.

Authors:  Ferdinando D'Amico; David T Rubin; Paulo Gustavo Kotze; Fernando Magro; Britta Siegmund; Taku Kobayashi; Pablo A Olivera; Peter Bossuyt; Lieven Pouillon; Edouard Louis; Eugeni Domènech; Subrata Ghosh; Silvio Danese; Laurent Peyrin-Biroulet
Journal:  United European Gastroenterol J       Date:  2021-05-07       Impact factor: 4.623

3.  Assessment of circulating biomarkers for potential pharmacodynamic utility in patients with lymphoma.

Authors:  A Greystoke; J P B O'Connor; K Linton; M B Taylor; J Cummings; T Ward; F Maders; A Hughes; M Ranson; T M Illidge; J Radford; C Dive
Journal:  Br J Cancer       Date:  2011-01-18       Impact factor: 7.640

Review 4.  Markers of Toxicity and Response to Radiation Therapy in Patients With Prostate Cancer.

Authors:  Nicola J Nasser; Jonathan Klein; Abed Agbarya
Journal:  Adv Radiat Oncol       Date:  2020-10-27

5.  Immune molecular profiling of a multiresistant primary prostate cancer with a neuroendocrine-like phenotype: a case report.

Authors:  Scott G Williams; Han Xian Aw Yeang; Catherine Mitchell; Franco Caramia; David J Byrne; Stephen B Fox; Sue Haupt; Ralf B Schittenhelm; Paul J Neeson; Ygal Haupt; Simon P Keam
Journal:  BMC Urol       Date:  2020-10-28       Impact factor: 2.264

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.